<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>INTRODUCTION: Excessive use of <z:chebi fb="0" ids="37962">adrenergic agents</z:chebi> may result in <z:e sem="disease" ids="C0206145" disease_type="Disease or Syndrome" abbrv="">stunned myocardium</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>CASES: We report the cases of two patients with <z:hpo ids='HP_0002138'>subarachnoid hemorrhage</z:hpo> (SAH) complicated by cardiogenic shock secondary to triple-H therapy for <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Both patients had <z:mpath ids='MPATH_458'>normal</z:mpath> cardiac function on admission and no signs of <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> at the <z:hpo ids='HP_0003674'>onset</z:hpo> of cardiogenic shock </plain></SENT>
<SENT sid="3" pm="."><plain>Intra-aortic balloon pump (IABP) counterpulsation was used to maintain adequate cerebral perfusion while enabling the high doses of <z:chebi fb="1" ids="18357,33569">norepinephrine</z:chebi> that were being administered to be reduced </plain></SENT>
<SENT sid="4" pm="."><plain>Reversal of the myocardial dysfunction after vasopressors were discontinued supported a diagnosis of <z:chebi fb="2" ids="33567">catecholamine</z:chebi>-induced <z:e sem="disease" ids="C0206145" disease_type="Disease or Syndrome" abbrv="">stunned myocardium</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>CONCLUSION: IABP counterpulsation may be one therapeutic option for patients with vasospasm after SAH when high doses of vasopressors can induce severe myocardial dysfunction </plain></SENT>
<SENT sid="6" pm="."><plain>However, this invasive device may not be sufficient to maintain adequate cerebral perfusion and fatal embolic events can complicate the clinical course </plain></SENT>
</text></document>